Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2021-05, Vol.96 (5), p.E168-E171
Hauptverfasser:	Morabito, Fortunato, Tripepi, Giovanni, Del Poeta, Giovanni, Mauro, Francesca Romana, Reda, Gianluigi, Sportoletti, Paolo, Laurenti, Luca, Coscia, Marta, Herishanu, Yair, Varettoni, Marzia, Murru, Roberta, Chiarenza, Annalisa, Visentin, Andrea, Condoluci, Adalgisa, Moia, Riccardo, Pietrasanta, Daniela, Loseto, Giacomo, Consoli, Ugo, Scortechini, Ilaria, Rossi, Francesca Maria, Zucchetto, Antonella, Vigna, Ernesto, Martino, Enrica Antonia, Mendicino, Francesco, Botta, Cirino, Caracciolo, Daniele, Cassin, Ramona, D'Arrigo, Graziella, Galimberti, Sara, Rago, Angela, Angeletti, Ilaria, Biagi, Annalisa, Del Giudice, Ilaria, Bomben, Riccardo, Neri, Antonino, Fronza, Gilberto, Cutrona, Giovanna, Rossi, Davide, Di Raimondo, Francesco, Cuneo, Antonio, Gaidano, Gianluca, Polliack, Aaron, Trentin, Livio, Foà, Robin, Ferrarini, Manlio, Gattei, Valter, Gentile, Massimo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - analogs & derivatives Adenine - therapeutic use Aged Antineoplastic Agents - therapeutic use Chronic lymphocytic leukemia Datasets as Topic - statistics & numerical data Female Follow-Up Studies Hematology Humans Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - mortality Male Middle Aged Multicenter Studies as Topic Piperidines - therapeutic use Prognosis Progression-Free Survival Proportional Hazards Models Protein Kinase Inhibitors - therapeutic use Reproducibility of Results Retrospective Studies Risk Assessment Severity of Illness Index Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!